MAZZALI, CRISTINA
MAZZALI, CRISTINA
Dipartimento di Scienze Biomediche e Cliniche
Mapping the COVID-19 epidemic in Lombardy, Italy, years 2020–2022: a population-based study of temporal trends, geographic distribution, and risk factors for incidence, hospitalization, and mortality
2026 S. Villa, P. Magnoni, C. Mazzali, A. Zucchi, G. Maifredi, L. Cavalieri D'Oro, M.L. Gambino, A.C. Fanetti, P.G. Perotti, M. Villa, M.G. Valsecchi, D. Vigani, C. Lucifora, F.E. Pregliasco, D. Cereda, O. Leoni, A.G. Russo, N. Null, F. Franzoni, G. Letta, L. Antolini, G. Lapadula, E. Tassistro, S. Denicolai, M. Grego, D. Kabbara, C. Baldrighi, A. Milanese, R. Murtas, A. Salvatori, D. Testa, S. Tunesi, A. Zanfino, S. Dalle Carbonare, F. Manzoni, S. Migliazza, L. Guarda, S. Tillati, G. Crotti, G. Sampietro, A. Andreano, E. Merlo, M. Rognoni, P. Fontana, I. Cometti, M. Lanzoni, G.E. La Piana, A. Bussi, V. Belcastro, S. Rusconi, L. Magnani, M. Morlotti, A. Patroni, R. Bruno, E. Pagani, P. Sacchi, V. Zuccaro
Epidemiological trends of infective endocarditis in a single center in Italy between 2003–2015
2018 L. Ferraris, L. Milazzo, S.G. Rimoldi, C. Mazzali, A. Barosi, M.R. Gismondo, P. Vanelli, A. Cialfi, S. Sollima, M. Galli, C. Antona, S. Antinori
Effect of cobicistat on tenofovir disoproxil fumarate (TDF): what is true for TAF may also be true for TDF
2018 D. Cattaneo, D. Minisci, S. Baldelli, C. Mazzali, A. Giacomelli, L. Milazzo, P. Meraviglia, C. Resnati, G. Rizzardini, E. Clementi, M. Galli, C. Gervasoni
Effects of different regimens of iron prophylaxis on maternal iron status and pregnancy outcome : a randomized control trial
2017 F. Parisi, C. Berti, C. Mandò, A. Martinelli, C. Mazzali, I. Cetin
Renal function in HIV/HBV co-infected and HBV mono-infected patients on a long-term treatment with tenofovir in real life setting
2017 L. Milazzo, C. Gervasoni, F.S. Falvella, D. Cattaneo, C. Mazzali, P. Ronzi, F. Binda, S. Cheli, S. Sollima, S. Antinori
SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir
2015 L. Milazzo, A.M. Peri, C. Mazzali, C. Magni, E. Calvi, A. De Nicolò, E. Clementi, S. Cheli, A. D'Avolio, S. Antinori, F.S. Falvella
ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors
2015 A. Lombardi, S. Landonio, C. Magni, S. Cheli, C. Mazzali, M.U. Mondelli, G. Rizzardini, E. Clementi, F.S. Falvella
DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan
2015 F.S. Falvella, S. Cheli, A. Martinetti, C. Mazzali, R. Iacovelli, C. Maggi, M. Gariboldi, M.A. Pierotti, M. Di Bartolomeo, E. Sottotetti, R. Mennitto, I. Bossi, F. de Braud, E. Clementi, F. Pietrantonio
Pharmacokinetic interactions between telaprevir and antiretroviral drugs in HIV/HCV-coinfected patients with advanced liver fibrosis and prior HCV non-responders
2015 L. Milazzo, D. Cattaneo, E. Calvi, C. Gervasoni, C. Mazzali, P. Ronzi, A.M. Peri, A.L. Ridolfo, A. D'Avolio, S. Antinori
Use of administrative data in healthcare research
2015 C. Mazzali, P. Duca
Methodological Issues in the Use of Administrative Databases to Study Heart Failure
2015 C. Mazzali, M. Maistriello, F. Ieva, P. Barbieri
Candidaemia observed at a University Hospital in Milan (Northern Italy) and review of published studies from 2010 to 2014
2014 L. Milazzo, A.M. Peri, C. Mazzali, R. Grande, C. Cazzani, D. Ricaboni, A. Castelli, F. Raimondi, C. Magni, M. Galli, S. Antinori
Acceptability of meningococcal serogroup B vaccine among parents and health care workers in Italy: a survey
2014 C. Mameli, M. Faccini, C. Mazzali, M. Picca, G. Colella, P.G. Duca, G.V. Zuccotti
Profile of infective endocarditis observed from 2003 - 2010 in a single center in Italy
2013 L. Ferraris, L. Milazzo, D. Ricaboni, C. Mazzali, G. Orlando, G. Rizzardini, M. Cicardi, F. Raimondi, L. Tocalli, A. Cialfi, P. Vanelli, M. Galli, C. Antona, S. Antinori
A population based study of hospitalised seriously injured in a region of Northern Italy
2013 O. Chiara, C. Mazzali, S. Lelli, A. Mariani, S. Cimbanassi
Short communication: impact of hepatitis C viral clearance on CD4+ T-lymphocyte course in HIV/HCV-coinfected patients treated with pegylated interferon plus ribavirin
2012 L. Milazzo, A. Foschi, C. Mazzali, A. Viola, A. Ridolfo, M. Galli, S. Antinori
Liver-Related Factors Associated with Low Vitamin D Levels in HIV and HIV/HCV Coinfected Patients and Comparison to General Population
2011 L. Milazzo, C. Mazzali, G. Bestetti, E. Longhi, A. Foschi, A. Viola, T. Vago, M. Galli, C. Parravicini, S. Antinori
Mucosal healing predicts late outcomes after the first course of corticosteroids for newly diagnosed ulcerative colitis
2011 S. Ardizzone, A. Cassinotti, P. Duca, C. Mazzali, C. Penati, G. Manes, R. Marmo, A. Massari, P. Molteni, G. Maconi, G.B. Porro
Fluvastatin as an adjuvant to pegylated interferon and ribavirin in HIV/epatitis C virus genotype 1 co-infected patients : an open-label randomized controller study
2010 L. Milazzo, I. Caramma, C. Mazzali, M. Cesari, M.A. Olivetti, M. Galli, S. Antinori
P.R.U.O. (Protocollo di Revisione di Utilizzo dell'Ospedale) riabilitativo : definizione e validazione dello strumento
2007 E. Rossetti, L. Bevilacqua, S. Castaldi, E. Alliata, A.P. Cantù, C. Cavallo, R. Curci, D. Di Napoli, C. Mazzali, S. Sidoti, F. Auxilia